Nova Patents
IL255029B

Predicting response to alvocidib by mitochondrial profiling

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

30 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
62150138United States of America–
201562150138United States of AmericaP
2016028443United States of AmericaW

Members30

Family members, oldest first
DocumentOfficeKind
US2016303101A1United States of AmericaA1
CA2982928A1CanadaA1
WO2016172214A1World Intellectual Property Organization (WIPO)A1
AU2016252609A1AustraliaA1
MX2017013383AMexicoA
IL255029A0IsraelA0
IL255029D0IsraelD0
KR20180018507ARepublic of KoreaA
US9901574B2United States of AmericaB2
EP3286564A1European Patent Office (EPO)A1
CN107995863AChinaA
JP2018516245AJapanA
BR112017022666A2BrazilA2
US2019030017A1United States of AmericaA1
HK1251655AHong Kong, ChinaA
HK1251655A1Hong Kong, ChinaA1
RU2017140030ARussian FederationA
US10357488B2United States of AmericaB2
US2019282557A1United States of AmericaA1
RU2017140030A3Russian FederationA3
EP3611506A1European Patent Office (EPO)A1
RU2717829C2Russian FederationC2
US10624880B2United States of AmericaB2
US2021052568A1United States of AmericaA1
JP6851978B2JapanB2
EP3611506B1European Patent Office (EPO)B1
IL255029AIsraelA
IL255029BThis recordIsraelB
AU2016252609B2AustraliaB2
BR112017022666A8BrazilA8